Evidence map›Paper›PMID 31461914›Full record

ReviewMolecules (Basel, Switzerland)2019

Neuroprotective Potential of Secondary Metabolites from

Zeinab Abdulwanis Mohamed, Enas Mohamed Eliaser, Emanuela Mazzon, Patrick Rollin, Gwendoline Cheng Lian Ee, Ahmad Faizal Abdull Razis

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. 7-Geranyloxycinnamic Acid Isolated fromMolecules (Basel, Switzerland) · 2023
    Article
  5. Review
  6. Aqueous extract ofFrontiers in pharmacology · 2022
    Article
  7. Neuroprotective Effects of 7-Geranyloxycinnamic Acid fromMolecules (Basel, Switzerland) · 2020
    Article
  8. Anti-Fungal Efficacy and Mechanisms of Flavonoids.Antibiotics (Basel, Switzerland) · 2020
    Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zeinab Abdulwanis MohamedLaboratory of Molecular Biomedicine, Institute of Bioscience, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia.
Enas Mohamed EliaserLaboratory of Molecular Biomedicine, Institute of Bioscience, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia.
Emanuela MazzonIRCCS Centro Neurolesi "Bonino-Pulejo", Via Provinciale Palermo, Contrada Casazza, 98124 Messina, Italy.ORCID 0000-0002-5073-717X
Patrick RollinUniversité d'Orléans et CNRS, ICOA, UMR 7311, BP 6759, F-45067 Orléans, France.ORCID 0000-0001-5951-9614
Gwendoline Cheng Lian EeChemistry Department, Faculty of Science, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia.
Ahmad Faizal Abdull RazisLaboratory of Molecular Biomedicine, Institute of Bioscience, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia. madfaizal@upm.edu.my.ORCID 0000-0001-9205-3764

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plant natural compounds have great potential as alternative medicines for preventing and treating diseases.

Indexed as

Secondary MetabolismAnimalsAnti-Inflammatory AgentsAntioxidantsHumansMedicine, TraditionalMolecular StructureNeuroprotective AgentsPhytochemicalsRutaceaeAnti-Inflammatory AgentsAntioxidantsNeuroprotective AgentsPhytochemicalsalkaloidscoumarinsMelicope lunu-ankendaneurodegenerative diseasesneuroprotectionpolyphenols

Identifiers

PMID31461914
PMCPMC6749319

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.